Kagawa Chiaki
University of Yamanashi, Interdisciplinary Graduate School of Medicine and Engineering, 1110 Shimokato, Chuo-shi, Yamanashi 409-3898, Japan.
Brain Nerve. 2009 Jan;61(1):11-7.
There have been considerable disputes the positioning of neuroethics as a new field since its emergence in 2002. It is the novelty of the neuroethical issues and the necessity for updated moral approaches to them that leading exponents of neuroethics have emphasized; advances in neurosciences have created an entirely new field of moral inquiries that the conventional bioethics had never noticed. Futher, as neuroethics embraces the subdivision of ethics in neuroscience, it should take precedence over bioethics, which depends on the fundamental moral concepts without questioning their bases. Many bioethicists have squarely opposed these insistences and thereby detected the claim of neuroethics exceptionalism: the asserted newness of issues comes mainly from the ignorance of exponents of this new field regarding accumulated bioethical inquiries, so that the overlapping concerns between bioethics and neuroethics are passed on to the future by them. Moreover, bioethicists point out that the recent tendency of Balkanization in the field of bioethics could endanger the integrity of moral investigations. Subfields of bioethics, such as geneethics, neuroethics, nanoethics and so on, originate consecutively, entail wastage of valuable time and money, and increase the risk of fragmentizing moral considerations in an inconsistent way. By reviewing this controversy between neuroethics and bioethics, I argue that the relevant scientific investigations and technologies, which have appeared to promote the proliferation of bioethical sub-disciplines to date, are beginning to converge into 1 complex that demands not the division into subspecialities but the novel integration of bioethical inquiries: it is time to attempt the unification of bioethical applied ethics for moral considerations regarding nano-bio-info-cogno convergent technologies.
自2002年神经伦理学作为一个新领域出现以来,关于其定位一直存在相当大的争议。神经伦理学的主要倡导者强调了神经伦理问题的新颖性以及对其采用更新道德方法的必要性;神经科学的进展创造了一个传统生物伦理学从未关注过的全新道德探究领域。此外,由于神经伦理学涵盖了神经科学中的伦理学细分领域,它应该优先于生物伦理学,因为生物伦理学依赖于基本的道德概念而不质疑其基础。许多生物伦理学家坚决反对这些观点,从而察觉到了神经伦理学例外论的主张:所宣称的问题新颖性主要源于这个新领域的倡导者对已积累的生物伦理探究的忽视,以至于他们将生物伦理学和神经伦理学之间的重叠关注点传递到了未来。此外,生物伦理学家指出,生物伦理学领域最近的巴尔干化趋势可能危及道德研究的完整性。生物伦理学的子领域,如基因伦理学、神经伦理学、纳米伦理学等等,相继产生,导致宝贵的时间和金钱的浪费,并增加了以不一致的方式分割道德考量的风险。通过审视神经伦理学和生物伦理学之间的这场争议,我认为,迄今为止似乎推动了生物伦理学子学科扩散的相关科学研究和技术,正开始汇聚成一个复杂的整体,它要求的不是细分为子专业,而是对生物伦理探究进行新颖的整合:现在是尝试统一生物伦理应用伦理学,以对纳米 - 生物 - 信息 - 认知融合技术进行道德考量的时候了。